BioQ Pharma products

invenious connect-and-go technology is already being used to deliver infusibles in a patented range of infusion systems. Our products are thoughtfully-designed to each drug – with bespoke solutions for: Drugs requiring complex weight-based dosing. Cytotoxic drugs. Drugs that need to be reconstituted or diluted at time of use. Drug-drug combinations, including for cold-chain products.

The invenious™ platform transforms infusible drugs into a ‘connect-and-go’ package. invenious offers multiple benefits to pharmaceutical companies. For pharmaceutical companies seeking fast, efficient ways to unlock extra revenue growth, the invenious™ platform could offer a safe, proven and more efficient alternative to reformulation. Invenious™ infusion systems does this for: Infusible medicines whose market performance is held back by complex preparation and administration. Products approaching loss of exclusivity.

The Ropivacaine Readyfusor infusion pharmaceutical is pre-filled and is intended to provide a safer, more efficient solution (at a lower total cost) than fillable pain pumps. Our Ropivacaine Readyfusor pharmaceutical is applicable to surgical procedures conducted in hospitals and surgery centers. BioQ Pharma markets Ropivacaine Readyfusor through a variety of partners worldwide.

Propofol  is one of the world’s most commonly used procedural anesthetic agents. invenious/propofol features programmable flow and bolus capabilities. Our ready-to-use invenious/propofol pharmaceutical presentation has been designed with the intent to help providers increase patient throughput, while improving safety and sterility for patients. BioQ Pharma is marketing invenious/propofol through our worldwide commercial partners.